Introduction {#section1-1534735418790387}
============

Breast cancer patients have a decline in balance function and postural instability 1 to 3 months after chemotherapy.^[@bibr1-1534735418790387]^ Falls are associated with risk factors unique to people with cancer, including peripheral neuropathy, steroid myopathy, cachexia, and deconditioning.^[@bibr2-1534735418790387],[@bibr3-1534735418790387]^ A recent study demonstrated less postural steadiness of cancer patients compared with age-matched controls.^[@bibr4-1534735418790387]^ Breast cancer patients have balance impairments and neuromuscular dysfunction from symptoms of chemotherapy-induced peripheral neuropathy.^[@bibr5-1534735418790387]^ Furthermore, breast cancer patients who have received chemotherapy show significantly increased postural instability compared with matched controls.^[@bibr6-1534735418790387]^ Previous case reports showed that cancer survivors have a decline in potential balance function after treatment is stopped and there is a need for further research in this population.^[@bibr7-1534735418790387]^ Another study showed that breast cancer survivors have decreased muscle strength compared with healthy subjects.^[@bibr8-1534735418790387]^ Decreased levels of lower limb strength are associated with poor balance function in the elderly.^[@bibr9-1534735418790387],[@bibr10-1534735418790387]^ Therefore, it is hypothesized that the decline in balance function among cancer survivors is related to muscle strength. However, to date, there has been no research to investigate the relationship. The purpose of this study is to investigate the differences in balance function among cancer survivors and healthy subjects. Furthermore, we aimed to identify the potential loss of balance function and assess the relationship between balance function and muscle strength in these 2 groups.

Methods {#section2-1534735418790387}
=======

Study Design {#section3-1534735418790387}
------------

This study was a prospective, observational investigation of balance and muscle strength among cancer survivors and healthy subjects.

Participants and Methods {#section4-1534735418790387}
------------------------

Cancer survivors and healthy subjects were recruited in the Relay for Life Niigata in Japan in August 2017, using a poster describing the study aim regarding balance function and muscle strength assessment, which explained that cancer survivors and healthy subjects were needed for the research. Cancer survivors and healthy subjects aged 18 years or older with Eastern Cooperative Oncology Group Performance Status Score 0 or 1 were enrolled.^[@bibr11-1534735418790387]^ The cancer survivors had to be able to walk and carry out work without any problems, thereby having an Eastern Cooperative Oncology Group Performance Status Score of 0 or 1. Additionally, cancer survivors who could not complete muscle strength tests and balance function assessments were excluded. Consequently, 19 cancer survivors and 14 healthy subjects were included ([Table 1](#table1-1534735418790387){ref-type="table"}). Cancer survivors and healthy subjects participated in one assessment session in our study. The mean ages were not significantly different: 51.5 years (±SD 11.2) for cancer survivors and 47.4 years (±SD 14) for healthy subjects. Six of 19 cancer survivors were men (31.6%) as were 3 of 14 healthy subjects (21.4%). No significant difference was observed in the men-women ratio or mean height or body weight between the 2 groups. However, body mass index was significantly higher in the cancer survivors (*P* \< .05). Cancer survivor diagnoses included breast cancer, retroperitoneal sarcoma, acute leukemia, lung cancer, colorectal cancer, thyroid cancer, Ewing's sarcoma, and tongue cancer.

###### 

Demographics and Clinical Characteristics in Cancer Survivors and Healthy Subjects^[a](#table-fn2-1534735418790387){ref-type="table-fn"}^.

![](10.1177_1534735418790387-table1)

  Characteristics              Cancer Survivors (n = 19)   Healthy Subjects (n = 14)   *P*
  ---------------------------- --------------------------- --------------------------- ------
  Age, years                   51.5 ± 11.2                 47.4 ± 14                   .354
  Men, n (%)                   6 (31.6)                    3 (21.4)                    .518
  Women, n (%)                 13 (68.4)                   11 (78.6)                   
  Height, cm                   160.1 ± 6.9                 160.6 ± 9.7                 .856
  Body weight, kg              62.4 ± 12                   54.3 ± 17.5                 .121
  BMI, kg/m^2^                 24.3 ± 4.2                  20.6 ± 4                    .018
  Diagnosis, n                                                                         
   Breast cancer               9                                                       
   Retroperitoneal sarcoma     1                                                       
   Acute leukemia              3                                                       
   Lung cancer                 1                                                       
   Colorectal cancer           2                                                       
   Thyroid cancer              1                                                       
   Ewing's sarcoma             1                                                       
   Tongue cancer               1                                                       
  Duration of disease (days)                                                           
   Mean ± SD                   2116 ± 1566                                             
   Median (range)              1517 (390-5900)                                         

Abbreviation: BMI, body mass index.

Values are presented as mean ± SD unless stated otherwise. Statistical analysis at baseline was performed using an independent Student's *t* test and Pearson's χ^2^ test where appropriate.

The Niigata University of Health and Welfare Institutional Committee on Human Research approved the study, and written informed consent was obtained from all participants.

Timed Up and Go Test (TUG) {#section5-1534735418790387}
--------------------------

TUG is a reliable and valid test for quantifying functional mobility that may also be useful in monitoring clinical changes over time.^[@bibr12-1534735418790387]^ Furthermore, TUG also has been used to measure balance function.^[@bibr13-1534735418790387],[@bibr14-1534735418790387]^ TUG was performed in our study by asking the participants to sit comfortably in a chair and timing, with a stopwatch, how long it took them to stand up and walk 3 m, turn around, walk back, and sit down again.^[@bibr12-1534735418790387]^ The time to complete the test was recorded. Participants were asked to perform 2 TUG trials at each testing session, and the fastest of the 2 measurements in seconds was used for analysis.

Body Sway Testing {#section6-1534735418790387}
-----------------

Body sway was measured using a gravicorder force platform (GS-10, Anima Inc, Tokyo, Japan). Subjects stood for 30 seconds while looking at a round mark (3 cm in diameter) placed 2 meters in front of their eyes. Researchers ensured that the subjects looked at the mark during all measurements. The velocity of the locus of the gravity-center sway (postural sway) was recorded. The center of pressure (CoP), as the index of postural stability, was measured once using the gravicorder force platform under a 20-Hz sampling rate. Tasks were performed under 2 conditions: eyes open and eyes closed. The total length of CoP (cm), the area of CoP (cm^2^), and length per area (cm/cm^2^) were calculated.

Muscle Strength {#section7-1534735418790387}
---------------

### Hand Grip Strength {#section8-1534735418790387}

Hand grip strength (kg) was evaluated using a standard adjustable-handle dynamometer (TKK5101; Takei Scientific Instruments, Niigata, Japan) positioned at the second grip position for all subjects. The dynamometer was adjusted to each participant's hand size. During the assessment, participants were requested to stand upright with feet shoulder-width apart and look forward, with their elbows fully extended. The dynamometer was held by the testing hand with the grip meter indicator facing outward, and away from any part of the body. Participants were instructed to squeeze the grip with full force, continuously for at least 2 seconds.^[@bibr15-1534735418790387],[@bibr16-1534735418790387]^ Hand grip strength, measured bilaterally, was used as an index of upper limb strength.

### Knee-Extensor Muscle Strength {#section9-1534735418790387}

Knee-extensor muscle strength (kg) was measured as an index of lower limb strength using a hand-held dynamometer (µ-TAS MT1; Anima, Tokyo, Japan). For all measurements, a stabilizing belt was used to aid the tester in applying resistance. Knee extension force was tested with subjects sitting with the knee flexed at approximately 60°. The dynamometer was applied to the anterior surface of the tibia, proximal to the malleoli. The maximum force developed during 10 seconds of static effort was recorded.

Hand grip strength and knee-extensor muscle strength were normalized to body weight and these muscle strength measurements were expressed as a percent of body weight.

Statistical Analysis {#section10-1534735418790387}
--------------------

All quantitative variables are expressed as mean ± SD unless stated otherwise. Demographic and clinical characteristics were compared using Student's *t* test for continuous measures and Pearson's χ^2^ test for ordinal variables. The Student's *t* test was used to compare hand grip and knee-extensor muscle strength based on body weight, TUG time, and body sway parameters. Statistical analysis was performed using SPSS 19.0J (SPSS Japan Inc, Tokyo, Japan) with *P* values \<.05 considered statistically significant.

Results {#section11-1534735418790387}
=======

[Table 2](#table2-1534735418790387){ref-type="table"} shows the mean values for muscle strength and balance function for all subjects. Both hand grip strength and left knee strength were significantly decreased in cancer survivors compared with healthy subjects (*P* \< .05). No significant differences were found with respect to right knee-extension strength between the 2 groups. TUG time was significantly higher in cancer survivors (*P* \< .05). With eyes open, the area of the CoP was significantly larger in cancer survivors than in healthy subjects (*P* \< .05). Similarly, the length per area was significantly lower both with eyes open and closed for cancer survivors compared with healthy subjects (*P* \< 0.05). However, there were no significant differences in CoP length or CoP area between the 2 groups with eyes closed.

###### 

Differences in Muscle Strength and Balance Function Among Cancer Survivors and Healthy Subjects^[a](#table-fn4-1534735418790387){ref-type="table-fn"}^.

![](10.1177_1534735418790387-table2)

  Variables                                                                        Cancer Survivors (n = 19)   Healthy Subjects (n = 14)   *P*           
  -------------------------------------------------------------------------------- --------------------------- --------------------------- ------ ------ ------
  Right hand grip (kgf/BW)                                                         0.42                        0.12                        0.56   0.09   .001
  Left hand grip (kgf/BW)                                                          0.41                        0.11                        0.54   0.06   .000
  Right knee ext (kgf/BW)                                                          0.38                        0.11                        0.45   0.12   .098
  Left knee ext (kgf/BW)                                                           0.36                        0.09                        0.44   0.09   .020
  Timed Up and Go test (s)                                                         6.1                         0.8                         5.0    0.7    .000
  Eyes open                                                                                                                                              
   Length of CoP (cm)                                                              43.8                        18.3                        38.8   8.6    .349
   Area of CoP (cm^2^)^[b](#table-fn5-1534735418790387){ref-type="table-fn"}^      3.0                         2.0                         1.7    0.9    .018
   Length/area (cm/cm^2^)^[b](#table-fn5-1534735418790387){ref-type="table-fn"}^   17.7                        7.9                         26.9   10.6   .007
  Eyes closed                                                                                                                                            
   Length of CoP (cm)                                                              58.5                        25.2                        53.2   16.6   .501
   Area of CoP (cm^2^)^[b](#table-fn5-1534735418790387){ref-type="table-fn"}^      2.7                         1.2                         2.1    1.2    .141
   Length/area (cm/cm^2^)^[b](#table-fn5-1534735418790387){ref-type="table-fn"}^   22.8                        6.8                         29.8   9.9    .033

Abbreviations: BW, body weight; CoP, center of pressure; ext, extension.

Values are presented as mean ± SD unless. Statistical testing was performed using Student's *t* test.

Area means environmental area of CoP.

[Table 3](#table3-1534735418790387){ref-type="table"} shows the relationship between muscle strength and balance function for cancer survivors and healthy subjects. Left hand grip strength and left knee extension strength were significantly negatively correlated with TUG results in cancer survivors (*P* \< .05). Similarly, right hand grip strength and right knee extension strength were negatively correlated with TUG in healthy subjects (*P* \< .05). However, there was no significant relationship between muscle strength and body sway parameters for eyes open or closed.

###### 

Correlation Between Muscle Strength and Balance Function for Cancer Survivors and Healthy Subjects^[a](#table-fn7-1534735418790387){ref-type="table-fn"}^.

![](10.1177_1534735418790387-table3)

                                                                                                                 Eyes Open Condition   Eyes Closed Condition            
  -------------------------- ------------------ ---------------------------------------------------------------- --------------------- ----------------------- -- -- -- --
  Right hand grip (kgf/BW)   Cancer survivors                                                                                                                           
                             Healthy subjects   −0.638[\*](#table-fn8-1534735418790387){ref-type="table-fn"}                                                            
  Left hand grip (kgf/BW)    Cancer survivors   −0.740[\*\*](#table-fn8-1534735418790387){ref-type="table-fn"}                                                          
                             Healthy subjects                                                                                                                           
  Right knee ext (kgf/BW)    Cancer survivors                                                                                                                           
                             Healthy subjects   −0.616[\*](#table-fn8-1534735418790387){ref-type="table-fn"}                                                            
  Left knee ext (kgf/BW)     Cancer survivors   −0.468[\*](#table-fn8-1534735418790387){ref-type="table-fn"}                                                            
                             Healthy subjects                                                                                                                           

Abbreviations: CoP, center of pressure; BW, body weight; ext, extension.

Statistical analysis using Pearson correlation coefficient. Only significant correlation coefficients are presented.

*P* \< .05. \*\**P* \< .01.

Discussion {#section12-1534735418790387}
==========

Previous studies have shown that breast cancer survivors had significantly decreased lower limb strength compared with healthy subjects,^[@bibr17-1534735418790387]^ although survivors of Hodgkin's lymphoma had no differences in muscle strength compared with healthy subjects.^[@bibr18-1534735418790387]^ In the current study, cancer survivors had significantly decreased muscle strength compared with healthy subjects.

Nasopharyngeal cancer survivors have been reported to have significantly shorter one-leg-stance times than healthy subjects.^[@bibr19-1534735418790387]^ Our study showed that cancer survivors have higher TUG times compared with healthy subjects. The TUG test assesses a person's mobility and requires both static and dynamic balance. Therefore, cancer survivors may have a decreased balance function compared with healthy subjects.

In our previous research, patients with hematological cancer had significant increases in CoP length after chemotherapy and transplantation compared with before.^[@bibr20-1534735418790387]^ We found a significantly larger CoP area for cancer survivors than for healthy subjects. In both the eyes open and closed conditions, cancer survivors have a significantly lower length per area than healthy subjects. These results showed that cancer survivors have impaired body sway function, but it has also been demonstrated that cancer survivors can improve sway velocity in both the eyes open and closed conditions after 13 weeks of combined aerobic and resistance training exercise.^[@bibr21-1534735418790387]^ Our study suggests that it may be necessary to assess balance function, including TUG time and body sway parameters using a force platform, in order to identify potential loss of balance function in cancer survivors.

Therefore, we investigated the relationship between muscle strength and balance function including TUG and the body sway test. Muscle strength tended to be related to TUG performance. It is interesting that left muscle strength was significantly related to TUG scores in the cancer survivor group, but in healthy subjects, right muscle strength was significantly related to TUG. There are no previous reports of differences in strength and TUG scores on the left and right sides in other populations. Cancer survivors and healthy subjects may have different characteristics for muscle strength as measured by TUG. No relationship with muscle strength was observed for body sway test parameters in cancer survivors or healthy subjects. A previous study showed that hand grip strength is associated with body sway among older adults.^[@bibr22-1534735418790387]^ This relationship was not observed in this study due to the very small population.

Study Limitations {#section13-1534735418790387}
-----------------

The findings of this study should be considered in light of some limitations. First, we demonstrated differences in muscle strength and balance function between only 2 groups. The decrease of balance function in cancer survivors has some confounding factors, such as sex, age, treatment, physical activity, body fat, and somatosensory function on impaired balance function. Second, we did not have detailed clinical information for the cancer survivors; thus, we cannot investigate the differences in muscle strength and balance function by diagnosis and the effect of chemotherapy and radiation. In a future study, we will evaluate balance function in a larger group of cancer survivors and healthy subjects. Despite these limitations, we believe that the findings will be relevant in for planning rehabilitation and fall prevention for cancer survivors.

Conclusion {#section14-1534735418790387}
==========

Cancer survivors have significantly decreased balance function compared with healthy subjects. TUG results have a relationship with muscle strength, but the body sway test does not. These findings might be helpful for planning future studies of exercise therapies for cancer survivors. Other types of investigation may shed light on some of our puzzling results Evaluation of one-leg standing, functional reach, and the Berg balance scale would be useful to measure balance function in cancer survivors beyond the TUG and body sway tests used in this study.
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